Home Newsletters Pulmonary Cell News Pretreatment with Valproic Acid Alleviates Pulmonary Fibrosis through Epithelial–Mesenchymal Transition Inhibition In...

Pretreatment with Valproic Acid Alleviates Pulmonary Fibrosis through Epithelial–Mesenchymal Transition Inhibition In Vitro and In Vivo

0
In vitro, epithelial-mesenchymal transition (EMT) was induced by the administration of transforming growth factor-β1 in a human alveolar epithelial cell line.
[Laboratory Investigation]
7753456 {7753456:RT2ET24M} apa 50 1 163830 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-7e8fc9aace65c5a772dc7b8e9aec3bcc%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22RT2ET24M%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EChen%2C%20L.%2C%20Alam%2C%20A.%2C%20Pac-Soo%2C%20A.%2C%20Chen%2C%20Q.%2C%20Shang%2C%20Y.%2C%20Zhao%2C%20H.%2C%20Yao%2C%20S.%2C%20%26amp%3B%20Ma%2C%20D.%20%282021%29.%20Pretreatment%20with%20valproic%20acid%20alleviates%20pulmonary%20fibrosis%20through%20epithelial%26%23x2013%3Bmesenchymal%20transition%20inhibition%20in%20vitro%20and%20in%20vivo.%20%3Ci%3ELaboratory%20Investigation%3C%5C%2Fi%3E%2C%201%26%23x2013%3B10.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41374-021-00617-2%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41374-021-00617-2%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DRT2ET24M%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pretreatment%20with%20valproic%20acid%20alleviates%20pulmonary%20fibrosis%20through%20epithelial%5Cu2013mesenchymal%20transition%20inhibition%20in%20vitro%20and%20in%20vivo%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lin%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azeem%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurelie%22%2C%22lastName%22%3A%22Pac-Soo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22You%22%2C%22lastName%22%3A%22Shang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hailin%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shanglong%22%2C%22lastName%22%3A%22Yao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daqing%22%2C%22lastName%22%3A%22Ma%22%7D%5D%2C%22abstractNote%22%3A%22Epithelial%5Cu2013mesenchymal%20transition%20%28EMT%29%20plays%20a%20crucial%20role%20in%20the%20development%20of%20pulmonary%20fibrosis.%20This%20study%20aims%20to%20investigate%20the%20effects%20of%20valproic%20acid%20%28VPA%29%20on%20EMT%20in%20vitro%20and%20in%20vivo.%20In%20vitro%2C%20EMT%20was%20induced%20by%20the%20administration%20of%20transforming%20growth%20factor-%5Cu03b21%20%28TGF-%5Cu03b21%29%20in%20a%20human%20alveolar%20epithelial%20cell%20line%20%28A549%29.%20The%20dose%20effects%20of%20VPA%20%280.1%5Cu20133%5Cu2009mM%29%20on%20EMT%20were%20subsequently%20evaluated%20at%20different%20timepoints.%20VPA%20%281%5Cu2009mM%29%20was%20applied%20prior%20to%20the%20administration%20of%20TGF-%5Cu03b21%20and%20the%20expression%20of%20E-cadherin%2C%20vimentin%2C%20p-Smad2%5C%2F3%20and%20p-Akt%20was%20assessed.%20In%20addition%2C%20the%20effects%20of%20a%20TGF-%5Cu03b2%20type%20I%20receptor%20inhibitor%20%28A8301%29%20and%20PI3K-Akt%20inhibitor%20%28LY294002%29%20on%20EMT%20were%20evaluated.%20In%20vivo%2C%20the%20effects%20of%20VPA%20on%20bleomycin-induced%20lung%20fibrosis%20were%20evaluated%20by%20assessing%20variables%20such%20as%20survival%20rate%2C%20body%20weight%20and%20histopathological%20changes%2C%20whilst%20the%20expression%20of%20E-cadherin%20and%20vimentin%20in%20lung%20tissue%20was%20also%20evaluated.%20A8301%20and%20LY294002%20were%20used%20to%20ascertain%20the%20cellular%20signaling%20pathways%20involved%20in%20this%20model.%20The%20administration%20of%20VPA%20prior%20to%20TGF-%5Cu03b21%20in%20A549%20cells%20prevented%20EMT%20in%20both%20a%20time-%20and%20concentration-dependent%20manner.%20Pretreatment%20with%20VPA%20downregulated%20the%20expression%20of%20both%20p-Smad2%5C%2F3%20and%20p-Akt.%20A8301%20administration%20increased%20the%20expression%20of%20E-cadherin%20and%20reduced%20the%20expression%20of%20vimentin.%20LY294002%20inhibited%20Akt%20phosphorylation%20induced%20by%20TGF-%5Cu03b21%20but%20failed%20to%20prevent%20EMT.%20Pretreatment%20with%20VPA%20both%20increased%20the%20survival%20rate%20and%20prevented%20the%20loss%20of%20body%20weight%20in%20mice%20with%20pulmonary%20fibrosis.%20Interestingly%2C%20both%20VPA%20and%20A8301%20prevented%20EMT%20and%20facilitated%20an%20improvement%20in%20lung%20structure.%20Overall%2C%20pretreatment%20with%20VPA%20attenuated%20the%20development%20of%20pulmonary%20fibrosis%20by%20inhibiting%20EMT%20in%20mice%2C%20which%20was%20associated%20with%20Smad2%5C%2F3%20deactivation%20but%20without%20Akt%20cellular%20signal%20involvement.%22%2C%22date%22%3A%222021-06-24%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41374-021-00617-2%22%2C%22ISSN%22%3A%221530-0307%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41374-021-00617-2%22%2C%22collections%22%3A%5B%2243ZBJFKZ%22%5D%2C%22dateModified%22%3A%222021-06-24T17%3A07%3A58Z%22%7D%7D%5D%7D
Chen, L., Alam, A., Pac-Soo, A., Chen, Q., Shang, Y., Zhao, H., Yao, S., & Ma, D. (2021). Pretreatment with valproic acid alleviates pulmonary fibrosis through epithelial–mesenchymal transition inhibition in vitro and in vivo. Laboratory Investigation, 1–10. https://doi.org/10.1038/s41374-021-00617-2 Cite
Full Article
Exit mobile version